EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain.Published in:Journal of Pain Research, 2017, v. 10, p. 439, doi. 10.2147/JPR.S128520By:Keppel Hesselink, Jan M.;Schatman, Michael E.Publication type:Article
As drug target reemerges, the question is to block or stimulate it.Published in:Nature Medicine, 2014, v. 20, n. 3, p. 222, doi. 10.1038/nm0314-222By:Willyard, CassandraPublication type:Article